PD-1 Inhibitors - Globe Thesis

Keyword [PD-1 Inhibitors] Result: 21 - 40 \| Page: 2 of 4
21.	Efficacy Of PD-1 Inhibitors In Cross-line Therapy In Patients With Non-small Cell Lung Cancer
22.	Effect Of PD-1 Inhibitor On Myocardial Inflammation Microenvironment And Radiation Injury
23.	Meta-analysis Of The Efficacy And Safety Of PD-1 Inhibitors In The Treatment Of Advanced Tumors
24.	Immune Checkpoint Inhibitors And Endocrine Diseases:A Systematic Review And Meta-analysis
25.	Prognostic Value Of Peripheral Blood Biomarkers LIPI Or NLR For Survival Outcomes In Patients With Solid Tumors Receiving PD-1 Inhibitors
26.	Experimental Study Of Calcium Peroxide Nanomaterials Synergistically Enhance The Efficacy Of TACE And PD-1 Inhibitors For Liver Cancer
27.	Pivotal Roles Of Tumor-Draining Lymph Nodes In The Effect For Combined Immunotherapy And Radiotherapy
28.	The Study On Application Of TKIs Combined With PD-1 Inhibitors In Conversion Resection And Postoperative Adjuvant Therapy For Hepatocellular Carcinoma
29.	Lactobacillus Acidophilus Enhanced PD-1 Inhibitors Antitumor-immunity In A Lewis Lung Cancer Mouse Model After Antibiotics Treatment
30.	Studies Of PD-1 Inhibitors And PD-1 Inhibitors Combined With Chemotherapy In Gestational Trophoblastic Neoplasia
31.	The Role Of CMTM6 In The Superior Efficacy Of Combination Of HDAC Inhibitors And PD-1 Inhibitors And Its Immunomodulation In Lung Adenocarcinoma
32.	Clinical Efficacy And Safety Of PD-1 Inhibitors And Its Combination With Other Drugs In Advanced Non-small Cell Lung Cancer: A Real-world Study
33.	The Role And Mechanism Of CircRAPGEF5 In Non-small Cell Lung Cancer Treated With PD-1 Inhibitors
34.	Efficacy And Safety Analysis Of PD-1 Inhibitor Combined With Recombinant Human Endostatin And Chemotherapy In First-Line Treatment Of Advanced Non-small Cell Lung Cancer
35.	To Explore The Prediction Effect Of CD39+CD8+T Cell Ratio In Peripheral Blood Of Non-small Cell Lung Cancer Patients Using PD-1 Inhibitors
36.	Efficacy Of PD-1 Inhibitors In Combination With Different Anti-Angiogenic Agents In Non-Small Cell Lung Cancer
37.	Construction Of Management Scheme For Immune Related Fatigue Of PD-1 Inhibitors In Cancer Patients
38.	Efficacy And Safety Of Fruquintinib And Regorafenib Combined With PD-1 Inhibitors In The Third-line And Beyond Treatment Of Advanced Colorectal Cancer
39.	The Value Of Peripheral Blood M1/M2 Macrophage Ratio In Assessing The Efficacy Of PD-1 Inhibitors In The Treatment Of Advanced Hepatocellular Carcinoma
40.	Real World Study Of Immune Related Adverse Events Caused By PD-1 Inhibitors And Efficacy Correlation
<<First <Prev Next> Last>> Jump to